66,514 results match your criteria Percutaneous Coronary Intervention


Remote ischaemic conditioning in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention: an updated meta-analysis of clinical outcomes.

Acta Cardiol 2020 Jul 3:1-9. Epub 2020 Jul 3.

Department of Cardiology, Deutsches Hospital, Buenos Aires, Argentina.

All previous meta-analyses including clinical outcomes after remote ischaemic conditioning (RIC) in patients with ST-elevation myocardial infarction STEMI) treated with percutaneous coronary intervention (PCI) demonstrated that RIC significantly reduced all-cause mortality and major adverse cardiovascular events (MACE). Following the publication of these meta-analyses, three new randomised controlled clinical trials (RCT) including 5712 patients were reported. The objective of this study was to perform an updated meta-analysis about the effectiveness of RIC in reducing MACE in patients with STEMI undergoing PCI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00015385.2020.1766259DOI Listing

Towards a lesion-specific approach to percutaneous coronary intervention for bifurcation lesions.

Eur Heart J 2020 Jul 3. Epub 2020 Jul 3.

Division of Cardiology and Angiology II, University Heart Centre Freiburg - Bad Krozingen, Bad Krozingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehaa559DOI Listing

Percutaneous coronary intervention in dextrocardia: a case report and a brief review of the literature.

J Cardiovasc Med (Hagerstown) 2020 Aug;21(8):613-615

Interventional Cardiology Unit, Azienda Ospedaliera Universitaria di Parma, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2459/JCM.0000000000000927DOI Listing

Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization.

Catheter Cardiovasc Interv 2020 Jul 3. Epub 2020 Jul 3.

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Objectives: This study aimed to evaluate the association between improvement in exercise capacity and functional completeness of revascularization, determined by residual functional SYNTAX score (rFSS), which is the sum of residual SYNTAX score of the vessels with post- percutaneous coronary intervention (PCI) quantitative flow ratio (QFR) ≤0.80.

Background: In patients with stable ischemic heart disease (SIHD), the efficacy of PCI in improving exercise capacity has been under debate and the differential effect of PCI for exercise capacity, according to functional completeness of revascularization, has not been evaluated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29118DOI Listing

Implication of Impella-supported percutaneous coronary intervention.

Authors:
Teruhiko Imamura

Catheter Cardiovasc Interv 2020 Jul 3. Epub 2020 Jul 3.

Second Department of Internal Medicine, University of Toyama, Toyama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29122DOI Listing

Outcomes of a Provincial Myocardial Infarction Reperfusion Strategy: A Population-Based, Retrospective Cohort Study.

Prehosp Disaster Med 2020 Jul 3:1-5. Epub 2020 Jul 3.

Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Background: Fibrinolysis is an acceptable treatment for acute ST-segment elevation myocardial infarction (STEMI) when primary percutaneous coronary intervention (PCI) cannot be performed within 120 minutes. The American Heart Association has recommended Emergency Medical Services (EMS) interventions such as prehospital fibrinolysis (PHF), prehospital electrocardiogram (ECG), and hospital bypass direct to PCI center. Nova Scotia, Canada has incorporated these interventions into a unique province-wide approach to STEMI care. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1049023X20000801DOI Listing

Evaluation of a Novel Antiplatelet Therapy Strategy in Patients Undergoing Elective Percutaneous Coronary Intervention.

J Pharm Pract 2020 Jul 3:897190020933469. Epub 2020 Jul 3.

Division of Cardiology, VA San Diego Healthcare System, San Diego, CA, USA.

Background: Ticagrelor presents less thrombotic risk compared to clopidogrel in acute coronary syndromes. However, its role in dual antiplatelet therapy (DAPT)-naive patients with stable ischemic heart disease (SIHD) undergoing elective percutaneous intervention (PCI) remains unclear, including uncertainty in the method of conversion to clopidogrel for adequate coverage without increased bleeding risk.

Objective: Determine the safety and efficacy of ticagrelor loading and transitioning to clopidogrel in patients with SIHD undergoing elective PCI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0897190020933469DOI Listing

Benefit of dual antithrombotic therapy with direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and metaanalysis of randomized clinical trials.

Intern Emerg Med 2020 Jul 2. Epub 2020 Jul 2.

Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.

Antithrombotic treatment in patients with atrial fibrillation undergoing percutaneous coronary intervention is still debated. We conducted a meta-analysis of recent randomized controlled trials to evaluate the benefit of different antithrombotic strategies. Data were analyzed between May and September 2019. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11739-020-02402-3DOI Listing

Percutaneous left ventricular advanced support for 'protected' complex high-risk transcatheter mitral valve repair: a case series.

Eur Heart J Case Rep 2020 Jun 3;4(3):1-7. Epub 2020 Apr 3.

Cardiovascular Department, Interventional Cardiology Unit, Careggi University Hospital, Largo Brambilla 3, 50141 Florence, Italy.

Background: Currently, the use of advanced ventricular support systems during percutaneous mitral valve repair (PMVR) procedures is confined to very few selected cases in emergency or bailout situations. No cases are reported of planned use of ventricular support devices in the subgroup of high-risk patients undergoing PMVR.

Case Summary: We report two cases of planned and 'protected' procedures of PMVR with Impella CP mechanical circulatory support. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjcr/ytaa066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319845PMC

A case report of an iatrogenic coronary cameral fistula treated by retrograde percutaneous coronary intervention.

Eur Heart J Case Rep 2020 Jun 3;4(3):1-6. Epub 2020 May 3.

Department of Cardiology, Rangueil Hospital, 1 Avenue du Professeur Jean Poulhès, 31400 Toulouse, France.

Background: Acquired coronary cameral fistula is an extremely rare condition that involves an abnormal communication between a coronary artery and a cardiac chamber. It usually occurs after chest trauma or cardiovascular interventions, such as percutaneous coronary intervention (PCI) and is associated with various outcomes, ranging from a stable status to haemodynamic instability. Acquired coronary cameral fistula frequently arises from the right coronary artery and drains generally into the right ventricle. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjcr/ytaa094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319832PMC

Zero-iodinated contrast retrograde percutaneous coronary interventions of chronic total occlusions using gadolinium and imaging guidance: a case report of a patient with severe anaphylaxis to iodinated contrast.

Eur Heart J Case Rep 2020 Jun 3;4(3):1-7. Epub 2020 May 3.

Division of Cardiology, Department of Internal Medicine, Henry Ford Hospital, 2799 W. Grand Blvd, Detroit, MI 48202, USA.

Background: Gadolinium-based contrast agents have been used as an alternative to iodinated contrast agents for simple percutaneous coronary interventions (PCIs) in patients with obstructive coronary artery disease. Their use has been limited in complex PCI due to poor image quality with gadolinium contrast. Significant dilution of gadolinium is required in an effort to avoid malignant ventricular arrhythmias. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjcr/ytaa092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319803PMC

Outcome at Six Months After Primary Percutaneous Coronary Interventions Performed at a Rural Satellite Center of Sindh Province of Pakistan.

Cureus 2020 May 28;12(5):e8345. Epub 2020 May 28.

Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Introduction Primary percutaneous coronary intervention (PPCI) is now a well-established treatment of acute ST-elevation myocardial infarction (STEMI). For the first time in Pakistan, various off-site satellite centers are established to perform PPCI 24-hours. Our population mainly resides in the rural area with low literacy rate and poor socioeconomic conditions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.8345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325348PMC

Serum interleukin-18 levels as a predictor for patients with genetic dysfunction of cytochrome P450 2C19 in dual antiplatelet therapy with clopidogrel.

J Cardiol 2020 Jun 29. Epub 2020 Jun 29.

Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.

Background: P2Y reaction unit (PRU) is an index of platelet activity upon treatment with clopidogrel. In spite of suitable P2Y reactions in dual antiplatelet therapy (DAPT) with clopidogrel after percutaneous coronary intervention (PCI), cardiovascular events actually occur in some patients, possibly due to a genetic dysfunction of cytochrome P450 2C19 (CYP2C19), which is a major metabolic enzyme of clopidogrel. As testing the CYP2C19 phenotypes to predict such patients may lack general versatility in daily clinical practice, the aim of this study was to examine whether measuring the blood levels of some cytokines in patients showing desirable PRUs in DAPT with clopidogrel could be a substitute for testing the CYP2C19 phenotypes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jjcc.2020.06.008DOI Listing

Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry.

Korean J Intern Med 2020 Jul 3. Epub 2020 Jul 3.

Cardiovascular Center, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

Background/aims: Long-term benefit of vasodilating β-blockers is unknown. This study aimed to investigate the long-term benefit of vasodilating β-blockers over conventional β-blockers in patients with acute myocardial infarction (AMI).

Methods: Using nationwide prospective multicenter Korean Acute Myocardial Infarction Registry data, we analyzed 3-year clinical outcomes of 7,269 patients with AMI who received percutaneous coronary intervention (PCI) and β-blocker therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2020.135DOI Listing

Immediate versus deferred percutaneous coronary intervention for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials.

PLoS One 2020 2;15(7):e0234655. Epub 2020 Jul 2.

Department of Cardiovascular Diseases of the Elderly, Chenzhou First People's Hospital, Chenzhou, China.

Inconsistent results exist regarding the treatment effectiveness of immediate versus deferred percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). This meta-analysis aimed to evaluate the efficacy and safety of immediate versus deferred PCI in ACS patients. PubMed, EMBASE, and Cochrane Library electronic databases were systematically searched from their inception up to August 2019. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0234655PLOS

Impact of preoperative SYNTAX Scores on short-term outcome following coronary artery bypass grafting surgery in the patients with multi-vessels coronary artery disease.

Egypt Heart J 2020 Jul 2;72(1):36. Epub 2020 Jul 2.

Faculty of Medicine, Alexandria University, Sultan Hussein Street, Al Khartoum Square, Alexandria, Egypt.

Background: SYNTAX Scores I (SSI) assesses the complexity of CAD; SYNTAX Score II (SSII) uses both SSI and other clinical variables, in estimation of 4 years mortality following both coronary artery bypass grafting surgery (CABG) and percutaneous coronary intervention (PCI) and gives recommendations for the best revascularization strategy in a specific patient. Our aim is to investigate the impact of both SYNTAX Scores on short-term outcome following CABG.

Results: Prospectively, we studied 150 patients with multi-vessels coronary artery disease, referred to perform, elective primary isolated CABG. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s43044-020-00071-3DOI Listing

Cardiac Rehabilitation with Targeted Intensity Improves Cardiopulmonary Functions Accompanying with Reduced Copeptin Level in Patients with Coronary Artery Disease.

J Cardiovasc Transl Res 2020 Jul 1. Epub 2020 Jul 1.

Cardiac Rehabilitation Program, Shanghai Xuhui Central Hospital/Zhongshan-Xuhui Hospital, Fudan University/Shanghai Clinical Research Center, Chinese Academy of Sciences, 966 Middle Huaihai Road, Shanghai, 200031, China.

Cardiac rehabilitation (CR) plays an important role in cardiovascular disease prevention. Understanding the key component of CR such as training intensity and biomarkers reflecting cardiopulmonary functions may help to better target the rehabilitation program. Thirty-four consecutive patients with coronary artery disease after percutaneous coronary intervention participated in the CR program. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12265-020-10055-yDOI Listing

Association between the Door-to-balloon Time and Mid-term Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction.

Intern Med 2020 1;59(13):1597-1603. Epub 2020 Jul 1.

Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan.

Objective In primary percutaneous coronary intervention (PCI), the door-to-balloon time (DTBT) is known to be associated with in-hospital death in patients with ST-segment elevation myocardial infarction (STEMI). However, little is known regarding the association between the DTBT and the mid-term clinical outcomes in patients with STEMI. The purpose of this study was to investigate the association between the DTBT and mid-term all-cause death. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.4287-19DOI Listing

The Association of Depression with Type D Personality and Coping Strategies in Patients with Coronary Artery Disease.

Intern Med 2020 1;59(13):1589-1595. Epub 2020 Jul 1.

School of Health Sciences, Shinshu University, Japan.

Objective Depression in patients with coronary artery disease (CAD) has been a risk factor for adverse cardiovascular events. However, personality types, strategies for coping with stressors, and their associations with depression have not been fully elucidated in patients with CAD. This study explored depression in patients with CAD and examined its association with personality types and coping strategies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.3803-19DOI Listing

Efficacy and safety of an antithrombotic regimen for atrial fibrillation patients with acute coronary syndrome or those undergoing percutaneous coronary intervention: a meta-analysis.

Aging (Albany NY) 2020 Jul 1;12. Epub 2020 Jul 1.

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

This study evaluated the benefit of dual therapy in reducing ischemic events in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI). We searched PubMed, Cochrane Library, and ClinicalTrials.gov for randomized controlled trials (RCTs) comparing dual and triple therapies (oral anticoagulation plus aspirin and P2Y12 inhibitor) for AF patients with ACS or those undergoing PCI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/aging.103359DOI Listing

Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI.

BMC Cardiovasc Disord 2020 Jul 1;20(1):313. Epub 2020 Jul 1.

Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.

Background: Whether the underlying risk of high bleeding risk (HBR) influences the relationship of high thrombotic risk (HTR) features with adverse events after drug-eluting stent implantation remains unclear. The purpose of this study was to evaluate (1) the prognostic effect of ESC guideline-endorsed HTR features on long-term clinical outcomes and (2) whether the outcomes of HTR versus non-HTR features vary by HBR status.

Methods: Ten thousand one hundred sixty-seven consecutive patients who underwent percutaneous coronary intervention between January 2013 and December 2013 were prospectively enrolled in Fuwai PCI Registry. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12872-020-01600-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329419PMC

Intensive Training and Real-Time Quality Control by a Physiology Core Laboratory: Lessons From DEFINE-PCI.

Circ Cardiovasc Interv 2020 Jul 2;13(7):e009077. Epub 2020 Jul 2.

Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (M.M., A.M., Z.A.A., G.W.S., A.J.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.120.009077DOI Listing

Calcified Coronary Lesions Treated With Intravascular Lithotripsy: One-Year Outcomes.

J Invasive Cardiol 2020 Jul;32(7):E200-E201

North Shore Hospital, 124 Shakespeare Rd, Takapuna, Auckland 0620, New Zealand.

Calcified lesions often increase the complexity of percutaneous coronary intervention (PCI) and risk of future adverse events. Shockwave intravascular lithotripsy (S-IVL; Shockwave Medical) has been shown to be an effective calcium-modification tool in preparing calcified coronary lesions prior to stent placement. Its circumferential, pulsatile soundwaves provide a different mechanism to fracture calcium compared with existing devices such as rotational atherectomy and cutting balloons. Read More

View Article

Download full-text PDF

Source

An Overview of Contrast-Associated Acute Kidney Injury Following Lower-Extremity Percutaneous Peripheral Interventions.

J Invasive Cardiol 2020 Jul;32(7):276-282

Interventional Cardiology and Vascular Medicine, Department of Medicine, Division of Cardiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, MC 7872, San Antonio, TX 78229-3900 USA.

Contrast-associated acute kidney injury, resulting from the use of iodinated contrast media, is a well-known adverse event following endovascular procedures and is associated with poor prognosis when it happens. There is an abundance of literature studying acute kidney injury following percutaneous coronary interventions, with very few studies done in the setting of percutaneous peripheral intervention. Although both percutaneous coronary intervention and percutaneous peripheral intervention utilize iodinated contrast media, several differences exist that can affect the incidence and management of contrast-associated acute kidney injury. Read More

View Article

Download full-text PDF

Source

Shock in an Octogenarian During Percutaneous Coronary Intervention.

JAMA Cardiol 2020 Jul 1. Epub 2020 Jul 1.

Division of Cardiology, David Geffen School of Medicine, UCLA (University of California, Los Angeles), Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2020.1439DOI Listing

Determinants and Clinical Outcomes of Extended Dual Antiplatelet Therapy over 3 Years after Drug-Eluting Stent Implantation: A Retrospective Analysis.

Yonsei Med J 2020 Jul;61(7):597-605

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.

Purpose: Although current guidelines recommend the administration of dual antiplatelet therapy (DAPT) for up to 12 months after the implantation of a drug-eluting stent (DES), extended DAPT is frequently used in real-world practice.

Materials And Methods: From the Korean Multicenter Angioplasty Team registry, we identified a total of 1414 patients who used DAPT for >3 years after DES implantation (extended-DAPT group) and conducted a landmark analysis at 36 months after the index procedure. We evaluated the determinants for and long-term outcomes of extended DAPT and compared the occurrence of major adverse cardiovascular and cerebrovascular events (MACCE), defined as the composite of all-cause death, myocardial infarction, stent thrombosis, and stroke, between the extended-DAPT group and the guideline-DAPT group [DAPT <1 year after DES implantation (n=1273)]. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3349/ymj.2020.61.7.597DOI Listing

Can Clinical and Functional Outcomes Be Improved with an Intelligent "Internet Plus"-Based Full Disease Cycle Remote Ischemic Conditioning Program in Acute ST-elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention? Rationale and Design of the i-RIC Trial.

Cardiovasc Drugs Ther 2020 Jun 30. Epub 2020 Jun 30.

Department of Rehabilitation Medicine, The First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing, 210029, China.

Background: Acute ST-elevation myocardial infarction (STEMI) is associated with a high incidence of complications as well as a considerable hospitalization rate and economic burden. Preliminary evidence suggests that remote ischemic conditioning (RIC) is a promising non-invasive intervention that may effectively and safely reduce myocardial infarct size, subsequent cardiac events and complications, and mortality. However, RIC's cardio-protective effect remains under debate, especially for single timepoint RIC programs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10557-020-07022-9DOI Listing

An international survey in Latin America on the practice of interventional cardiology during the COVID-19 pandemic, with a particular focus on myocardial infarction.

Neth Heart J 2020 Jun 30. Epub 2020 Jun 30.

ICBA, Buenos Aires, Argentina.

Introduction: A reduction in the number of interventional cardiology procedures has emerged as a result of the COVID-19 pandemic. A survey was performed to quantify this decrease and the impact on the management of myocardial infarction in Latin America.

Methods: A telematic survey was conducted for all countries in Latin America. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12471-020-01440-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325476PMC

Safety and efficacy of short-term (1 to 3 months) dual antiplatelet therapy in patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials.

J Thromb Thrombolysis 2020 Jun 30. Epub 2020 Jun 30.

Knight Cardiovascular Institute, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR, 97239, USA.

Among patients who have undergone percutaneous coronary intervention (PCI), the use of dual antiplatelet therapy (DAPT) is associated with increased risk of bleeding, but decreased stent thrombosis and myocardial infarction unrelated to the stent. As PCI techniques and devices have progressed, the optimal duration of DAPT has come into question. We identified all randomized controlled trials (RCTs) of patients undergoing PCI, who received one or more drug eluting stents (DES) for stable coronary artery disease (CAD) or acute coronary syndrome (ACS), and randomized to short (1-3 months) versus standard duration DAPT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-020-02069-9DOI Listing

Impact of nutritional index on long-term outcomes of elderly patients with coronary artery disease: sub-analysis of the SHINANO 5 year registry.

Heart Vessels 2020 Jun 30. Epub 2020 Jun 30.

Department of Cardiovascular Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.

Nutritional status is a novel approach to prognostic assessment in patients with cardiovascular disease. However, assessment of nutritional status in elderly patients is challenging due to the significant differences between young patients. The TCBI (Triglycerides × Total cholesterol × Body Weight Index) is a novel and simple nutritional index for predicting long-term outcomes in patients with coronary artery disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00380-020-01659-0DOI Listing

Residual Right Coronary Artery Stenosis after Left Main Coronary Artery Intervention Increased the 30-Day Cardiovascular Death and 3-Year Right Coronary Artery Revascularization Rate.

J Interv Cardiol 2020 14;2020:4587414. Epub 2020 Jun 14.

Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Background: The outcomes of patients with concomitant left main coronary artery (LMCA) and right coronary artery (RCA) diseases are reportedly worse than those with only LMCA disease. To date, only few studies have investigated the clinical impact of percutaneous coronary intervention (PCI) on RCA stenosis during the same hospitalization, in which LMCA disease was treated. This study was aimed at comparing the outcomes between patients with and without right coronary artery intervention during the same hospital course for LMCA intervention. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2020/4587414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313166PMC

Remote Ischemic Conditioning in Patients with Acute Coronary Syndromes: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.

Clin Epidemiol 2020 10;12:595-605. Epub 2020 Jun 10.

Centre of Clinical Heart Research, Oslo University Hospital, Oslo, Norway.

Objective: To evaluate the efficacy of remote ischemic conditioning (RIC) as compared to no conditioning on clinical endpoints in acute coronary syndromes (ACS) patients undergoing percutaneous coronary intervention (PCI).

Design: Systematic review of randomized clinical trials (RCTs).

Material And Methods: Literature was searched up to September 13, 2019, and we identified a total of 13 RCTs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CLEP.S249785DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294110PMC

Stroke and spinal infarct caused by percutaneous coronary intervention.

BMJ Case Rep 2020 Jun 30;13(6). Epub 2020 Jun 30.

Cardiology, University of Louisville, Louisville, Kentucky, USA.

Acute ischaemic stroke is a known risk of percutaneous coronary intervention (PCI). The incidence of such complications has increased in frequency over the last decade due to higher comorbidity burden and increased complexity of PCI procedures. The overall incidence of post-PCI ischaemic stroke remains low at 0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2020-234804DOI Listing

Long-term mortality comparison of patients with acute myocardial infarction complicated by cardiogenic shock and treated with culprit-only or multivessel percutaneous coronary intervention.

Cardiovasc Revasc Med 2020 Jun 18. Epub 2020 Jun 18.

Division of Cardiology, Careggi-Hospital, Florence, Italy.

Objectives: We sought to determine whether, in a real word context of patients with Acute Myocardial Infarction (AMI), multivessel disease (MVD) and cardiogenic shock (CS), the successful treatment with primary percutaneous coronary intervention (p-PCI) of only culprit lesions (OC-PCI) is associated with better long-term mortality rates than multivessel PCI (MV-PCI) of all significant lesions.

Methods: From our registry of all consecutive patients admitted for AMI between January 1995 and December 2016 we selected those presenting with CS and MVD successfully treated with p-PCI, and compared those who underwent OC-PCI against MV-PCI, either during the p-PCI (MV-pPCI) or by staged revascularization (Staged-PCI) during hospitalization. The primary endpoint was 2-year all-cause death. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.06.021DOI Listing

Impella versus extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock.

Cardiovasc Revasc Med 2020 May 30. Epub 2020 May 30.

Department of Cardiology, Henry Ford Hospital, Detroit, MI, United States of America.

Background: Percutaneous ventricular assist devices and extracorporeal membrane oxygenation (ECMO) are increasingly used for mechanical circulatory support (MCS) in patients with acute myocardial infarction with cardiogenic shock (AMI-CS) in hospitals throughout the United States.

Methods: Using the National Inpatient Sample from October 2015 to December 2017, we identified hospital admissions that underwent percutaneous coronary intervention (PCI) and non-elective Impella or ECMO placement for AMI-CS using ICD-10 codes. Propensity-score matching was performed to compare both groups for primary and secondary outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.042DOI Listing

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome.

J Clin Med 2020 Jun 27;9(7). Epub 2020 Jun 27.

Department of Medicine, National Heart & Lung Institute, Imperial College, London SW3 6LY, UK.

Acute coronary syndrome and atrial fibrillation are both common and can occur in the same patient. Combination therapy with dual antiplatelet therapy and oral anticoagulation increases risk of bleeding. Where the two conditions coexist, careful consideration is needed to determine the optimal antithrombotic treatment to reduce the risks of future ischaemic events associated with both conditions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm9072020DOI Listing

The Impact of Red Cell Distribution Width on the Development of Contrast-Induced Nephropathy in Patients with Stable Coronary Artery Disease who Underwent Coronary Angiography.

Sisli Etfal Hastan Tip Bul 2018 28;52(3):190-195. Epub 2018 Sep 28.

Department of Cardiology, Health Sciences University Bagcilar Training and Research Hospital, Istanbul, Turkey.

Objectives: Contrast-induced nephropathy (CIN) accounts for 10% of all causes of hospital-acquired renal failure. The pathophysiological cellular mechanism of the CIN development remains unclear and seems to be multifactorial. Herein, we aimed to determine the role of red cell distribution width (RDW) in the development of CIN after elective percutaneous intervention in patients with stable coronary artery disease, which in our opinion has not been researched enough. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14744/SEMB.2018.75537DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315093PMC
September 2018

Health Literacy of Patients Attending Cardiac Rehabilitation.

J Cardiopulm Rehabil Prev 2020 Jul;40(4):249-254

Australian Centre for Heart Health, Melbourne, Australia (Drs Beauchamp and Jackson); Department of Medicine-Western Health, University of Melbourne, Australia (Dr Beauchamp); Australian Institute for Musculoskeletal Science, Melbourne, Australia (Dr Beauchamp); Monash University School of Rural Health, Warragul, Australia (Dr Beauchamp); Cardiac Rehabilitation Unit, Caulfield Hospital, Australia (Ms Sheppard and Dr Wise); Epworth Monash Rehabilitation Medicine Unit, Monash University, Australia (Dr Wise); Faculty of Health, Deakin University, Geelong, Australia (Dr Jackson); and Centre on Behavioural Health, University of Hong Kong, China (Dr Jackson).

Purpose: Cardiac rehabilitation (CR) is effective at reducing further cardiac events. However, dropout rates are high, and maintenance of behavioral change post-CR is challenging. Health literacy (HL) may influence self-management of cardiac risk, yet few studies have explored this association. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCR.0000000000000473DOI Listing

Health Literacy of Patients Attending Cardiac Rehabilitation.

J Cardiopulm Rehabil Prev 2020 Jun 19. Epub 2020 Jun 19.

Australian Centre for Heart Health, Melbourne, Australia (Drs Beauchamp and Jackson); Department of Medicine-Western Health, University of Melbourne, Australia (Dr Beauchamp); Australian Institute for Musculoskeletal Science, Melbourne, Australia (Dr Beauchamp); Monash University School of Rural Health, Warragul, Australia (Dr Beauchamp); Cardiac Rehabilitation Unit, Caulfield Hospital, Australia (Ms Sheppard and Dr Wise); Epworth Monash Rehabilitation Medicine Unit, Monash University, Australia (Dr Wise); Faculty of Health, Deakin University, Geelong, Australia (Dr Jackson); and Centre on Behavioural Health, University of Hong Kong, China (Dr Jackson).

Purpose: Cardiac rehabilitation (CR) is effective at reducing further cardiac events. However, dropout rates are high, and maintenance of behavioral change post-CR is challenging. Health literacy (HL) may influence self-management of cardiac risk, yet few studies have explored this association. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCR.0000000000000473DOI Listing

Response to letter to the editor on "Percutaneous coronary intervention underperforms in Takayasu Arteritis".

Int J Cardiol 2020 Jun 27. Epub 2020 Jun 27.

Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2020.06.037DOI Listing

Percutaneous Closure of Paravalvular Leak from a Rocking Mitral Valve in a 74-Year-Old Man at High Surgical Risk.

Tex Heart Inst J 2020 Apr;47(2):160-162

Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30322.

Dehiscence of a prosthetic heart valve or excessive rocking during the cardiac cycle is thought to preclude percutaneous paravalvular leak closure. However, surgical repair of paravalvular leak is associated with recurrent dehiscence and poor outcomes. We present the case of a symptomatic 74-year-old man in whom we performed percutaneous anchoring, involving multiple plugs and multimodal imaging, to stabilize a rocking mitral valve and close a substantial paravalvular leak caused by dehiscence. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14503/THIJ-18-6626DOI Listing

Triple-Guidewire Technique for Treating Stent Underexpansion in Severely Calcified Coronary Artery Lesions.

Tex Heart Inst J 2020 Apr;47(2):155-159

Sanford Cardiovascular Institute, Sanford Heart Hospital, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota 57105.

Stent underexpansion, a potential complication of percutaneous coronary intervention in severely calcified and stenotic coronary arteries, may result in in-stent thrombosis and restenosis. Different balloon-based and atheroablative techniques have been proposed to reduce the risk of these complications. We describe a simple triple-guidewire technique that we used to treat stent underexpansion in 2 elderly men. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14503/THIJ-18-6622DOI Listing

Robotic-Assisted Percutaneous Coronary Intervention Through Transradial Approach: Experience in 4 Patients with Complex Lesions.

Tex Heart Inst J 2020 Apr;47(2):144-148

Department of Internal Medicine, Sanford Cardiovascular Institute, Sanford USD Medical Center, University of South Dakota-Sanford School of Medicine, Sioux Falls, South Dakota 57105.

Robotic-assisted percutaneous coronary intervention can reduce the exposure of interventional cardiologists to radiation and minimize the risk of occupational orthopedic injuries from wearing heavy protective aprons. The PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) study showed the efficacy and safety of robotic-assisted procedures for relatively low-risk lesions in single coronary arteries. Several reports have described robotic-assisted treatment of complex high-risk lesions, mostly through the transfemoral approach. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14503/THIJ-17-6350DOI Listing

Transcatheter Coil Embolization in 17 Patients with 22 Coronary Artery Fistulas.

Tex Heart Inst J 2020 Apr;47(2):135-139

Department of Interventional Cardiology, Arkansas Heart Hospital, Little Rock, Arkansas 72211.

Coronary artery fistulas are rare anomalies that often become symptomatic with age. They are typically diagnosed incidentally during coronary angiography. The chief nonsurgical treatment is transcatheter coil embolization. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14503/THIJ-18-6786DOI Listing

Logistic regression analysis of risk factors for upper gastrointestinal bleeding induced by PCI in combination with double antiplatelet therapy for STEMI patients.

Authors:
B Tang S Xiao

Acta Gastroenterol Belg 2020 Apr-Jun;83(2):245-248

Department of Cardiology, Jingzhou Central Hospital, The Second Clinical Medical College, Yangtze University, Jingzhou, China.

Objective: To analyze the risk factors for upper gastrointestinal bleeding (UGIB) in patients with ST-segment elevation myocardial infarction (STEMI) during double antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI).

Methods: A total of 388 patients treated from January 2015 to September 2017 due to STEMI were selected. Thirty-two cases of UGIB occurring during DAPT after PCI were included as a UGIB group, and another 356 cases without UGIB were set as a control group. Read More

View Article

Download full-text PDF

Source

Single-access during Impella hemodynamic support utilizing the Railway system.

Catheter Cardiovasc Interv 2020 Jun 30. Epub 2020 Jun 30.

Allina Health, Metropolitan Heart and Vascular Institute, Minneapolis, Minnesota, USA.

A single-access technique during mechanical circulatory support (MCS) and percutaneous coronary intervention (PCI) has been described for those patients where an additional arterial access site is not available or desired. This technique utilizes the Impella (Abiomed, Danvers, MA) 14 French (F) sheath as a single-access point, with a 7 F sheath through the 14 F sheath hemostatic valve next to the Impella catheter (Abiomed). However, this technique is limited to a 7 F sheath or smaller and can be difficult requiring multiple attempts and limit guide catheter manipulation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29096DOI Listing

Neutrophil gelatinase-associated lipocalin is a predictor of complications in the early phase of ST-elevation myocardial infarction.

Med Glas (Zenica) 2020 Aug 1;17(2). Epub 2020 Aug 1.

Urology Clinic, Clinical Centre of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina.

Aim To evaluate a correlation of serum level of neutrophil gelatinase-associated lipocalin (NGAL) to the risk of the occurrence of complications in patients with the early phase of ST-segment elevation myocardical infarction (STEMI) treated with fibrinolytic therapy prior to percutaneous coronary intervention (PCI). Methods A total of 54 patients with the diagnosis of STEMI treated with fibrinolytic therapy (alteplase) prior to PCI were included. Patients were admitted to the Intensive Care Unit (ICU) of Clinic for Heart, Blood Vessel and Rheumatic Diseases in the period January to March 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17392/1139-20DOI Listing

Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization Guideline.

Cardiovasc Drugs Ther 2020 Jun 29. Epub 2020 Jun 29.

Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.

Purpose: The ischemic/bleeding trade-off of continuing dual antiplatelet therapy (DAPT) beyond 1 year after PCI for patients with high thrombotic risk (HTR) as endorsed by 2018 ESC/EACTS myocardial revascularization guidelines remain unknown.

Methods: Patients undergoing coronary stenting between January 2013 and December 2013 from the prospective Fuwai registry were defined as HTR if they met at least 1 ESC/EACTS guideline-endorsed HTR criteria. A total of 4578 patients who were at HTR and were events free at 1 year after the index procedure were evaluated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10557-020-07030-9DOI Listing
June 2020
3.189 Impact Factor

Partial sub-struts stenting technique for emergency treatment of very late LAD stent thrombosis: A case report.

Cardiovasc Revasc Med 2020 May 29. Epub 2020 May 29.

Department of Heart and Great Vessels, Sapienza University of Rome, Rome, Italy.

Although rare, stent thrombosis remains a severe complication after stent implantation owing to its high morbidity and mortality, and represents a challenging scenario for interventional cardiology. Sub-struts stenting could constitute a rare last-resort-bailout technique for recanalization. We present herein a case of acute coronary syndrome secondary to in-stent restenosis and very late thrombosis, successfully treated with a partial sub-struts stenting. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2020.05.037DOI Listing